Sucampo Pharmaceuticals (SCMP) Earns News Impact Rating of 0.24

News articles about Sucampo Pharmaceuticals (NASDAQ:SCMP) have trended somewhat positive on Wednesday, AlphaOne reports. The research firm, a service of Accern.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Spotlight

Resources